Skip to search.
 TSX Down 0.39% TSX Ventures Up 0.28%

Acorda Therapeutics, Inc. (ACOR)

-NasdaqGS
34.20 Up 1.26(3.83%) Mar 27, 4:00PM EDT
|After Hours : 34.20 0.00 (0.00%) Mar 27, 4:36PM EDT
Add to Portfolio
Prev Close:32.94
Open:32.80
Bid:N/A
Ask:34.30 x 100
1y Target Est:44.73
Beta:1.31
Earnings Date:May 4 - May 8 (Est.)
Day's Range:32.71 - 34.35
52wk Range:28.26 - 45.45
Volume:585,306
Avg Vol (3m):773,868
Market Cap:1.43B
P/E (ttm):81.43
EPS (ttm):0.42
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
ACORUp 3.83%1.43B
BIIBUp 0.22%100.85B
TEVADown 0.70%52.80B

Key Statistics

Forward P/E (1 yr):36.38
P/S (ttm):3.44
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :0.51
Quarterly EPS Est (Mar-15) :0.13
Mean Recommendation*:2.5
PEG Ratio (5 yr expected):2.02

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Acorda Therapeutics, Inc., a biopharmaceutical company, identifies, develops, and commercializes novel therapies for neurological disorders in the United States. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback